» Articles » PMID: 10852464

Male Hypogonadism Caused by Homozygous Deletion of Exon 10 of the Luteinizing Hormone (LH) Receptor: Differential Action of Human Chorionic Gonadotropin and LH

Overview
Specialty Endocrinology
Date 2000 Jun 14
PMID 10852464
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

We report the unique case of a patient with Leydig cell hypoplasia (LCH) type II caused by a genomic deletion resulting in the complete absence of exon 10 of the LH receptor (LHR). The patient presented at the age of 18 yr with retarded pubertal development, small testicles, and delayed bone maturation. LH was highly elevated, with very low serum testosterone levels. Genetic analysis revealed a homozygous deletion of approximately 5 kbp encompassing exon 10 of the LHR gene. Screening of family members demonstrated heterozygosity for the deletion, indicating autosomal recessive inheritance. At the time of examination, the patient displayed nearly normal male phenotype, but lacked pubertal development and was hypogonadal. Obviously, fetal male development sustained by hCG was normal, whereas LH action, important for pubertal development, was impaired. A hCG stimulation test induced testosterone biosynthesis and secretion within the normal range. Subsequently, hCG treatment was continued, resulting in an increase in testicular volume and the appearance of spermatozoa in the ejaculate after 16 weeks of treatment (5.3 million/mL). Despite highly elevated endogenous LH serum levels, the response to hCG indicates a possible dual mechanism of hormone binding and signal transduction for hCG and LH on a LHR that lacks exon 10. Furthermore, this patient represents the clinical counterpart of the normal male marmoset monkey (Callithrix jacchus), in which the expressed LHR lacks exon 10 in toto. This case provides important clinical insights about the possible role of exon 10 of the LHR in discriminating between LH and hCG actions.

Citing Articles

[Type II Leydig cell hypoplasia caused by gene mutation: a case report].

Jin K, Su Z, Jiao Y, Pan L, Jiang X, Yin J Zhongguo Dang Dai Er Ke Za Zhi. 2025; 27(2):225-228.

PMID: 39962787 PMC: 11838040. DOI: 10.7499/j.issn.1008-8830.2410074.


The role of luteinizing hormone activity in spermatogenesis: from physiology to clinical practice.

Esteves S, Humaidan P Reprod Biol Endocrinol. 2025; 23(Suppl 1):6.

PMID: 39800700 PMC: 11726975. DOI: 10.1186/s12958-024-01333-4.


LHCGR inactivating variants: single center experience and systematic review of phenotype-genotype of 46,XY and 46,XX patients.

Barnabas R, Jadhav S, Lila A, Kusuma Boddu S, Memon S, Arya S Endocr Connect. 2024; 13(11).

PMID: 39162678 PMC: 11466245. DOI: 10.1530/EC-24-0246.


Precise Correction of Lhcgr Mutation in Stem Leydig Cells by Prime Editing Rescues Hereditary Primary Hypogonadism in Mice.

Xia K, Wang F, Tan Z, Zhang S, Lai X, Ou W Adv Sci (Weinh). 2023; 10(29):e2300993.

PMID: 37697644 PMC: 10582410. DOI: 10.1002/advs.202300993.


Revisiting the gonadotropic regulation of mammalian spermatogenesis: evolving lessons during the past decade.

Bhattacharya I, Dey S, Banerjee A Front Endocrinol (Lausanne). 2023; 14:1110572.

PMID: 37124741 PMC: 10140312. DOI: 10.3389/fendo.2023.1110572.